Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 1458 results found since Jan 2013.

Plagues and People – The Coronavirus in a Historical Perspective
By Jan LundiusSTOCKHOLM / ROME, Mar 19 2020 (IPS) The human factor is intimately involved in the origin, spread, and mitigation of the Coronavirus and we cannot afford to ignore that our future existence depends on compassion and cooperation. Response matters! Some quarantined Italians might recall Giovanni Boccaccio´s The Decameron from 1353 in which people escaping the plague are secluded in a villa where they tell stories to each other. Boccaccio introduced his collection of short stories with an eyewitness account of horrifying human suffering in Florence, which in 1348 was struck by a ”pestilence” that every day...
Source: IPS Inter Press Service - Health - March 19, 2020 Category: International Medicine & Public Health Authors: Jan Lundius Tags: Global Headlines Health Humanitarian Emergencies TerraViva United Nations Women's Health Source Type: news

Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
This article reviews the pertinent clinical literature, technical guidance, and expert recommendations on use of ECMO in critically ill cases of COVID-19. Here, we present basic knowledge and opinions about COVID-19 and ECMO, review the evidence on ECMO use in Middle East Respiratory Syndrome (MERS) and H1N1 influenza, share the technical guidance and recommendations on use of ECMO in COVID-19, summarize the current use of ECMO against COVID-19 in China, and discuss the issues in use of ECMO in COVID-19. PMID: 32759887 [PubMed - in process]
Source: Medical Science Monitor - August 13, 2020 Category: Research Tags: Med Sci Monit Source Type: research

The Greatest Gift to Loved Ones This Covid Winter? Don ’t Infect Others
“Our biggest worry is Covid-19 fatigue,” a coronavirus expert says. “People are losing respect for the virus and letting their guard down, which is a bad idea.”
Source: NYT Health - November 16, 2020 Category: Consumer Health News Authors: Jane E. Brody Tags: Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Influenza Vaccination and Immunization Winter (Season) Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this management. ...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Viruses, Vol. 13, Pages 234: Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus
Tam Ian H. Brown Jinhua Liu Kin-Chow Chang The long-term control strategy of SARS-CoV-2 and other major respiratory viruses needs to include antivirals to treat acute infections, in addition to the judicious use of effective vaccines. Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for any disease bears testament to the challenges of antiviral development. We recently showed that non-cytotoxic levels of thapsigargin (TG), an inhibitor of the sarcoplasmic/endoplasmic reticulum (ER) Ca2+ ATPase pump, induces a potent host innate immune antivi...
Source: Viruses - February 3, 2021 Category: Virology Authors: Sarah Al-Beltagi Cristian Alexandru Preda Leah V. Goulding Joe James Juan Pu Paul Skinner Zhimin Jiang Belinda Lei Wang Jiayun Yang Ashley C. Banyard Kenneth H. Mellits Pavel Gershkovich Christopher J. Hayes Jonathan Nguyen-Van-Tam Ian H. Brown Jinhua Liu Tags: Article Source Type: research

The Pandemic of Coronavirus Disease 2019 (COVID-19)
Curr Mol Med. 2021 Nov 17. doi: 10.2174/1566524021666211117145216. Online ahead of print.ABSTRACTCurrently, the world is facing the emergence of a virus that causes pneumonia in humans, which has a higher probability of causing complications that include respiratory distress syndrome and death. The new coronavirus 2019 (2019-nCoV), which is currently known as SARS-CoV-2, is the cause of the Coronavirus disease 2019 (COVID-19) . This virus was first detected in Wuhan, Hubei Province of China, and appears to have been a zoonotic infection that has now adapted to humans. On March 11 2020, COVID-19 was announced as a pandemic ...
Source: Current Molecular Medicine - November 18, 2021 Category: Molecular Biology Authors: Nurshamimi Nor Rashid Source Type: research